Lotus eye hospital And Institute Limited announced its unaudited standalone financial results for the quarter ended December 31, 2025, revealing mixed performance with quarterly losses offset by positive nine-month results. The eye care specialist also made a key management appointment during its Board meeting held on February 11, 2026.

Financial Performance Overview

The company's Q3FY26 performance showed contrasting trends between revenue growth and profitability. While total income increased to ₹1,378.51 lakhs from ₹1,246.77 lakhs in the corresponding quarter of the previous year, the company reported a net loss of ₹26.07 lakhs compared to a loss of ₹23.91 lakhs in Q3FY25.

Nine-Month Performance Remains Positive

Despite the quarterly setback, the company's nine-month performance for the period ending December 31, 2025, demonstrated resilience with sustained profitability and revenue growth.

Expense Analysis and Operational Metrics

The company's total expenses for Q3FY26 increased to ₹1,416.07 lakhs from ₹1,289.12 lakhs in the previous year, representing a 9.85% rise. Key expense categories showed varying trends with employee benefit expenses rising to ₹313.76 lakhs from ₹295.62 lakhs, service expenses increasing significantly to ₹276.74 lakhs from ₹238.98 lakhs, and finance costs more than doubling to ₹28.54 lakhs from ₹12.63 lakhs. However, depreciation expenses decreased to ₹98.24 lakhs from ₹130.69 lakhs.

Key Management Appointment

The Board of Directors approved the appointment of Mr. Prathish S as Company Secretary & Compliance Officer, effective February 13, 2026. Mr. Prathish S is an Associate Member of the Institute of Company Secretaries of India with membership number A73669.

Company Operations and Outlook

Lotus Eye Hospital operates exclusively in the eye care segment, providing specialized sales and services. The company maintains a network of facilities across Tamil Nadu and Kerala, with locations in Coimbatore, Salem, Tirupur, Kochi, Karur, and Gobichettipalayam. The paid-up equity share capital remained stable at ₹2,079.63 lakhs with a face value of ₹10 per share. The financial results were reviewed by the Audit Committee and approved by the Board of Directors, with statutory auditors conducting a limited review of the quarterly results.

Lotus eye hospital and Institute Limited has announced the resignation of its Company Secretary and Compliance Officer, marking a significant change in the company's key managerial personnel. The healthcare services provider informed stock exchanges about this corporate development through an official communication dated February 09, 2026.

Key Personnel Change Details

Mr. M Achuth Menon has tendered his resignation from the position of Company Secretary and Compliance Officer due to personal reasons. The resignation follows proper corporate governance protocols and regulatory compliance requirements.

Regulatory Compliance

The company has fulfilled its disclosure obligations pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement), 2015. The announcement was made to both major stock exchanges where the company's shares are listed.

The disclosure includes references to SEBI Circular No HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated November 11, 2024, and last updated on January 30, 2026. The company has provided detailed documentation including the resignation letter for regulatory review.

Management Communication

In his resignation letter, M Achuth Menon expressed gratitude to the management, Board of Directors, and the entire organization for their support and cooperation during his tenure. The resignation letter was addressed to Sangeetha Sundaramoorthy, Managing Director of the company.

The official communication was signed by Sangeetha Sundaramoorthy, Managing Director (DIN: 01859252), ensuring proper authorization and corporate governance compliance. The company maintains its headquarters in Coimbatore with multiple locations across Tamil Nadu and Kerala, continuing its healthcare services operations.